APO-IRBESARTAN HCTZ 300/25 irbesartan and hydrochlorothiazide 300/25mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-irbesartan hctz 300/25 irbesartan and hydrochlorothiazide 300/25mg tablet blister pack

arrotex pharmaceuticals pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: lactose monohydrate; povidone; croscarmellose sodium; magnesium stearate; iron oxide yellow; iron oxide red; titanium dioxide; hypromellose; macrogol 4000; iron oxide black - for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

APO-IRBESARTAN HCTZ 300/12.5 irbesartan and hydrochlorothiazide 300/12.5mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-irbesartan hctz 300/12.5 irbesartan and hydrochlorothiazide 300/12.5mg tablet blister pack

arrotex pharmaceuticals pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; povidone; magnesium stearate; croscarmellose sodium; iron oxide yellow; iron oxide red; titanium dioxide; hypromellose; macrogol 4000 - for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

APO-IRBESARTAN HCTZ 150/12.5 irbesartan and hydrochlorothiazide 150/12.5mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-irbesartan hctz 150/12.5 irbesartan and hydrochlorothiazide 150/12.5mg tablet blister pack

arrotex pharmaceuticals pty ltd - irbesartan, quantity: 150 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; povidone; lactose monohydrate; croscarmellose sodium; iron oxide yellow; iron oxide red; titanium dioxide; hypromellose; macrogol 4000 - for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

APO-IRBESARTAN irbesartan 75mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-irbesartan irbesartan 75mg film-coated tablet blister pack

arrotex pharmaceuticals pty ltd - irbesartan, quantity: 75 mg - tablet, film coated - excipient ingredients: lactose monohydrate; croscarmellose sodium; povidone; magnesium stearate; titanium dioxide; hypromellose; macrogol 4000 - irbesartan is indicated for the following: for the treatment of hypertension. for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (equal to or greater than 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.

APO-IRBESARTAN irbesartan 300mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-irbesartan irbesartan 300mg film-coated tablet blister pack

arrotex pharmaceuticals pty ltd - irbesartan, quantity: 300 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; lactose monohydrate; magnesium stearate; povidone; titanium dioxide; hypromellose; macrogol 4000 - irbesartan is indicated for the following: for the treatment of hypertension. for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (equal to or greater than 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.

APO-IRBESARTAN irbesartan 150mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-irbesartan irbesartan 150mg film-coated tablet blister pack

arrotex pharmaceuticals pty ltd - irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: lactose monohydrate; povidone; croscarmellose sodium; magnesium stearate; titanium dioxide; hypromellose; macrogol 4000 - irbesartan is indicated for the following: for the treatment of hypertension. for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (equal to or greater than 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.

IRBESARTAN/HCT SANDOZ 300/25 irbesartan 300 mg/hydrochlorothiazide 25 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

irbesartan/hct sandoz 300/25 irbesartan 300 mg/hydrochlorothiazide 25 mg film-coated tablet blister pack

sandoz pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: hypromellose; iron oxide black; macrogol 6000; colloidal anhydrous silica; lactose monohydrate; titanium dioxide; croscarmellose sodium; purified talc; microcrystalline cellulose; hyprolose; iron oxide red; magnesium stearate - irbesartan/hct sandoz is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

IRBESARTAN/HCT SANDOZ 300/12.5 irbesartan 300 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

irbesartan/hct sandoz 300/12.5 irbesartan 300 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack

sandoz pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; hypromellose; lactose monohydrate; hyprolose; titanium dioxide; croscarmellose sodium; colloidal anhydrous silica; macrogol 6000; purified talc; microcrystalline cellulose; iron oxide red; iron oxide yellow - irbesartan/hct sandoz is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop) European Union - English - EMA (European Medicines Agency)

irbesartan hydrochlorothiazide zentiva (previously irbesartan hydrochlorothiazide winthrop)

sanofi-aventis groupe  - irbesartan, hydrochlorothiazide - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension. this fixed-dose combination is indicated in adult patients whose blood pressure is not adequately controlled on irbesartan or hydrochlorothiazide alone.

IRBESARTAN AMNEAL irbesartan 150 mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

irbesartan amneal irbesartan 150 mg tablets blister pack

amneal pharma australia pty ltd - irbesartan -